Effects of Dl-3-n-butylphthalide on Cognitive Functions and Blood-brain Barrier in Chronic Cerebral Hypoperfusion Rats
Author:
Ma Yang1, Chen Shiling1, Li Yuanwei1, Wang Jiahui1, Yang Jingfei1, Jing Jie1, Liu Xia1, Li Yunjie1, Wang Jingyi1, Zhang Ping1, Tang Zhouping1
Affiliation:
1. Huazhong University of Science and Technology
Abstract
Abstract
Purpose
Vascular cognitive impairment (VCI) has been one of the major types of cognitive impairment. Blood-brain barrier damage plays an essential part in the pathogenesis of VCI. At present, the treatment to VCI mainly focused on prevention, with no drug clinically approved for the treatment of VCI. This study aimed to investigate the effects of DL-3-n-butylphthalide (NBP) on VCI rats.
Methods
A modified bilateral common carotid artery occlusion (mBCCAO) model was applied to mimic VCI. The feasibility of the mBCCAO model was verified by laser Doppler, 13N-Ammonia-Positron Emission Computed Tomography (PET) and Morris Water Maze. Subsequently, Morris water maze experiment, Evans blue staining and western blot of tight junction protein were performed to evaluate the effect of different doses of NBP (40mg/kg, 80mg/kg) on the improvement of cognitive impairment and BBB disruption induced by mBCCAO. Immunofluorescence was employed to examine the changes of pericyte coverage in mBCCAO model and the effect of NBP on pericyte coverage were preliminarily explored.
Results
mBCCAO surgery led to obvious cognitive impairment and the decrease of whole cerebral blood flow, among which the blood flow in cortex, hippocampus and thalamus brain regions decreased more significantly. High-dose NBP (80 mg/kg) improved long-term cognitive function in mBCCAO rats, alleviated Evans blue leakage and reduced the loss of tight junction proteins (ZO-1, Claudin-5) in the early course of the disease, thereby exerting a protective effect on the blood-brain barrier. No significant changes in pericyte coverage were observed after mBCCAO.
Conclusions
High-dose NBP improved cognitive function in mBCCAO rats. High-dose NBP protected the integrity of BBB by upregulating TJ protein expression, rather than regulating pericyte coverage ratio. NBP could be a potential drug for the treatment of VCI.
Publisher
Research Square Platform LLC
Reference42 articles.
1. Arvanitakis, Z., Shah, R.C., and Bennett, D.A. (2019) Diagnosis and Management of Dementia: Review. JAMA 322(16) 1589–1599. doi: 10.1001/jama.2019.4782. 2. Choy, M., Ganesan, V., Thomas, D.L., Thornton, J.S., Proctor, E., King, M.D., et al. (2006) The chronic vascular and haemodynamic response after permanent bilateral common carotid occlusion in newborn and adult rats. J Cereb Blood Flow Metab 26(8) 1066–1075. doi: 10.1038/sj.jcbfm.9600259. 3. Daneman, R., Zhou, L., Kebede, A.A., and Barres, B.A. (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468(7323) 562–566. doi: 10.1038/nature09513. 4. Duncombe, J., Kitamura, A., Hase, Y., Ihara, M., Kalaria, R.N., and Horsburgh, K. (2017) Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin Sci (Lond) 131(19) 2451–2468. doi: 10.1042/CS20160727. 5. Han, Q.Y., Zhang, H., Zhang, X., He, D.S., Wang, S.W., Cao, X., et al. (2019) dl-3-n-butylphthalide preserves white matter integrity and alleviates cognitive impairment in mice with chronic cerebral hypoperfusion. CNS Neurosci Ther 25(9) 1042–1053. doi: 10.1111/cns.13189.
|
|